Detected ·
Sift Biosciences
——
Sift Biosciences closed an oversubscribed pre-seed round to advance their lead oncology program. The company is harnessing memory T-cells from past infections to treat cancer, autoimmune disease, and other immune dysfunctions.
- Website
- siftbio.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-19 20:17:39 UTC
- Signal ID
- 7e17ecfc-9428-4128-8b84-bdf77dc9ce8f
As the API returns it
{
"id": "7e17ecfc-9428-4128-8b84-bdf77dc9ce8f",
"created_at": "2026-05-19T20:17:39.338428Z",
"company_name": "Sift Biosciences",
"company_website_url": "siftbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/sift-biosciences",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Sift Biosciences closed an oversubscribed pre-seed round to advance their lead oncology program. The company is harnessing memory T-cells from past infections to treat cancer, autoimmune disease, and other immune dysfunctions.*"
}